Attached files
| file | filename |
|---|---|
| EX-21.1 - EX-21.1 - ALBIREO PHARMA, INC. | d31682_ex21-1.htm |
| EX-32.1 - EX-32.1 - ALBIREO PHARMA, INC. | d31682_ex32-1.htm |
| EX-31.1 - EX-31.1 - ALBIREO PHARMA, INC. | d31682_ex31-1.htm |
| EX-31.2 - EX-31.2 - ALBIREO PHARMA, INC. | d31682_ex31-2.htm |
| EXCEL - IDEA: XBRL DOCUMENT - ALBIREO PHARMA, INC. | Financial_Report.xls |
| 10-K - 10-K - ALBIREO PHARMA, INC. | d31682_10k.htm |
Exhibit 23.1
Board of Directors and Stockholders
Biodel Inc.
Danbury, Connecticut
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (Nos. 333-182877 and 333-188576) and the Registration Statements on Form S-8 (Nos. 333-144407, 333-168903 and 333-180409) of Biodel, Inc. of our report dated December 19, 2014, relating to the financial statements, which appears in this Form 10-K for the year ended September 30, 2014. Our report on the financial statements contains an explanatory paragraph regarding the Company's ability to continue as a going concern.
/s/BDO USA, LLP
New York, New York
December 19, 2014